Chlamydia antigens and corresponding DNA fragments and uses...

Details Chlamydia antigens and corresponding DNA fragments and uses... Chlamydia antigens and corresponding DNA fragments and uses...

2007-02-27

2007-02-27

Navarro, Mark (Department: 1645)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S320100, C514S04400A

Reexamination Certificate

active

10976917

ABSTRACT:
The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain ofChlamydia, specificallyC. pneumoniae, employing a vector containing a nucleotide sequence encoding a 60 kDa cysteine-rich membrane protein of a strain ofChlamydia pneumoniaeand a promoter to effect expression of the 60 kDa cysteine-rich membrane protein gene in the host. Modifications are possible within the scope of this invention.

REFERENCES:
patent: 4879213 (1989-11-01), Fox et al.
patent: 5776746 (1998-07-01), Denney
patent: 6020191 (2000-02-01), Scaria et al.
patent: 6255082 (2001-07-01), Lizardi
patent: 6521745 (2003-02-01), Murdin et al.
patent: 6559294 (2003-05-01), Griffais et al.
patent: 6693087 (2004-02-01), Murdin et al.
patent: 6808713 (2004-10-01), Murdin et al.
patent: 6822071 (2004-11-01), Stephens et al.
patent: 7019125 (2006-03-01), Murdin et al.
patent: 7070792 (2006-07-01), Murdin et al.
patent: 7081245 (2006-07-01), Murdin et al.
patent: 2002/0082402 (2002-06-01), Murdin et al.
patent: 2002/0094340 (2002-07-01), Murdin et al.
patent: 2002/0094985 (2002-07-01), Murdin et al.
patent: 2002/0099188 (2002-07-01), Murdin et al.
patent: 2002/0132994 (2002-09-01), Murdin et al.
patent: 2003/0100706 (2003-05-01), Murdin et al.
patent: 2004/0254130 (2004-12-01), Murdin et al.
patent: WO 97/46709 (1997-12-01), None
patent: WO 98/58953 (1998-12-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 00/24765 (2000-05-01), None
patent: WO00/27994 (2000-05-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 00/37494 (2000-06-01), None
patent: WO 00/46359 (2000-08-01), None
patent: WO 00/66739 (2000-11-01), None
patent: WO 01/21804 (2001-03-01), None
patent: WO 01/21811 (2001-03-01), None
patent: WO 01/40474 (2001-06-01), None
patent: WO 01/46224 (2001-08-01), None
patent: WO 01/81379 (2001-11-01), None
patent: WO 01/85972 (2001-11-01), None
patent: WO 02/02606 (2002-01-01), None
patent: WO 02/08267 (2002-01-01), None
Grayston et al. (1995),Journal of Infectious Diseases,168:1231.
Campos et al. (1995),Investigation of Opthalmology and Visual Science,36:1477.
Grayston et al. (1990)Journal of Infectious Diseases,161:618.
Marrie (1993),Clinical Infectious Diseases,18:501.
Wang et al. (1986),Chlamydial Infections,Cambridge University Press, Cambridge, p. 329.
Saikku et al. (1988),Lancet,ii: 983.
Thom et al. (1992),Jama,268:68.
Linnanmaki et al. (1993),Circulation,87:1030.
Saikku et al. (1992),Annals Internal Medicine,116:273.
Melnick et al. (1993),American Journal of Medicine,95:499.
Shor et al. (1992,South African Medical Journal,82:158.
Kuo et al. (1993),Journal of Infectious Diseases,167:841.
Kuo et al. (1993),Arteriosclerosis and Thrombosis,13:1501.
Campbell et al. (1995),Journal of Infectious Diseases,172:585.
Chiu et al. (1997),Circulation,96(7): 2144-2148.
Ramirez et al. (1996),Annals of Internal Medicine,125:979.
Jackson et al.36thICAAC,Abst. K121, p. 272, Sep. 15-18, 1996, New Orleans.
Fong et al. (1997),Journal of Clinical Microbiology,35:48.
Hahn et al. (1998),Ann. Allergy Asthma Immunol.,80(1): 45-49.
Hahn et al. (1996),Epidemiol. Infect.,117(3): 513-517.
Bjornsson et al. (1996),Scand. J. Infect. Dis.,28(1): 63-69.
Hahn (1995),J. Fam. Pract.,41(4): 345-351.
Allegra et al.,Eur. Respir. J.,7(12): 2165-2168.
Hahn et al. (1991),JAMA,266(2): 225-230.
Pal et al. (1996),Infection and Immunity,64: 5341.
Jones et al. (1995),Vaccine,13:715.
Igietseme et al. (1993),Regional Immunology,5:317.
Magee et al. (1993),Regional Immunology,5: 305.
Landers et al. (1991),Infection&Immunity,59:3774.
Magee et al. (1995),Infection&Immunity,63:516.
Cotter et al. (1995),Infection&Immunity,63:4704.
Campbell et al. (1990),Infection&Immunity,58:93.
McCafferty et al. (1995),Infection&Immunity,63:2387-9.
Gaydos et al. (1992),Infection&Immunity,60:5319 and 5323.
Wiedmann-Al-Ahmad et al. (1997),Clin. Diagn. Lab. Immunol.,6:700-704.
Hughes et al. (1992),Infect. Immun.,60(9): 3497.
Dion et al. (1990),Virology,179:474-477.
Snijders et al. (1991),J. Gen. Virol.,72:557-565.
Langeveld et al. (1994),Vaccine,12(15): 1473-1480.
Ausubel et al. (1994),Current Protocols in Microbiology,John Wiley and Sons.
Kunkel et al. (1985),Proc. Natl. Acad. Sci.USA, 82:448.
Silhavey et al. (1984),Experiments with Gene Fusion,Cold Spring Harbor Press.
Davis et al. (1980),A Manual for Genetic Engineering: Advanced Bacterial Genetics,Cold Spring Harbor Press.
Casey et al. (1977),Nucl. Acid. Res.,4:1539.
Cagnon et al. (1991),Protein Engineering,4(7): 843.
Takase et al. (1987),J. Bact.,169:5692.
Perez Melgosa et al. (1994),Infect. Immun.,62:880.
Watson et al. (1990),Nucleic Acids Res.,18(7):5299-5300.
Watson et al. (1995),Microbiology,141:2489.
Watson et al. (1994),Microbiology,140(8): 2003-2011.
Watson et al. (1994),Microbiology,32(11): 2820-2823.
Melgosa et al. (1993),FEMS Microbiol. Lett.,112:199.
Campbell et al. (1990),J. Clin. Microbiol.,28:1261.
Iijima et al. (1994),J. Clin. Microbiol.,32:583.
Bachmaier et al. (1999),Science,283:1335.
Ausubel et al. (1994),Current Protocols in Molecular Biology,John Wiley & Sons Inc., vol. 1.
Silhavy et al. (1994),Experiments with Gene Fusions,Cold Spring Harbor Laboratory Press, pp. 191-195.
Davis et al. (1980),A Manual for Genetic Engineering: Advanced Bacterial Genetics,Cold Spring Harbor Laboratory Press, pp. 174-176.
Plotkin et al., “Vaccines” W.B. Saunders Co. Philadelphia. 1988. p. 571.
Wagels et al. (1994),J. Clinical Microbiology,140(8): 2003-2011.
U.S. Appl. No. 09/857,128, filed Sep. 20, 2001, Murdin et al.
U.S. Appl. No. 09/868,987, filed Dec. 23, 1999, Murdin et al.
U.S. Appl. No. 09/471,194, filed Dec. 23, 1999, Murdin et al.
U.S. Appl. No. 09/522,606, filed Mar. 10, 2000, Murdin et al.
U.S. Appl. No. 09/609,243, filed Jun. 30, 2000, Murdin et al.
U.S. Appl. No. 09/662,813, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,362, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,360, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,361, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/662,814, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/662,812, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/709,473, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/709,474, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/709,384, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/747,349, filed Dec. 22, 2000, Murdin et al.
Stephens et al., “Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia Trachomatis,” Oct. 23, 1998, vol. 282, Science, pp. 754-759.
Kalman et al., “Comparative Genomes of Chlamydia Pneumoniae and C. Trachomatis,”Nature Genetics,vol. 21, Apr. 1999, pp. 385-389.
Mygind et al., “Analysis of the Humoral Immune Response toChlamydiaOuter Membrane Protein 2, ”Clinical and Diagnostic Laboratory Immunology,vol. 5, No. 3, May 1998, pp. 313-318.
Allen et al., “An intermolecular mechanism of T cell help for the production of antibodies to the bacterial pathogen,Chlamydia trachomatis,” Eur. J. Immunol.,vol. 23, 1993, pp. 1169-1172.

Affiliated with

Also associated with

Rating

Chlamydia antigens and corresponding DNA fragments and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chlamydia antigens and corresponding DNA fragments and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia antigens and corresponding DNA fragments and uses... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3818246